Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $44640.0 on Feb 25 ’25. In the deal valued at $4.46 per share,10,000 shares were bought. As a result of this transaction, Polymeropoulos Mihael Hristos now holds 2,331,730 shares worth roughly $10.4 million.
Then, Moran Kevin Patrick bought 2,000 shares, generating $8,779 in total proceeds. Upon buying the shares at $4.39, the SVP, CFO & Treasurer now owns 355,763 shares.
Before that, Mitchell Stephen Ray sold 5,000 shares. Vanda Pharmaceuticals Inc shares valued at $25,863 were divested by the Director at a price of $5.17 per share. As a result of the transaction, Mitchell Stephen Ray now holds 44,857 shares, worth roughly $0.2 million.
H.C. Wainwright initiated its Vanda Pharmaceuticals Inc [VNDA] rating to a Buy in a research note published on October 31, 2024; the price target was $18. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid July with a ‘”an Overweight”‘ rating. Jefferies also remained covering VNDA and has decreased its forecast on February 25, 2022 with a “Hold” recommendation from previously “Buy” rating. BofA Securities started covering the stock on May 12, 2021. It rated VNDA as “a Buy”.
Price Performance Review of VNDA
On Tuesday, Vanda Pharmaceuticals Inc [NASDAQ:VNDA] saw its stock jump 2.53% to $4.46. Vanda Pharmaceuticals Inc shares have fallen nearly -6.89% since the year began. Nevertheless, the stocks have risen 3.00% over the past one year. While a 52-week high of $6.75 was reached on 01/02/25, a 52-week low of $3.71 was recorded on 02/14/25. SMA at 50 days reached $4.59, while 200 days put it at $5.07.
Levels Of Support And Resistance For VNDA Stock
The 24-hour chart illustrates a support level at 4.34, which if violated will result in even more drops to 4.22. On the upside, there is a resistance level at 4.54. A further resistance level may holdings at 4.62. The Relative Strength Index (RSI) on the 14-day chart is 46.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.73%. Stochastics %K at 33.86% indicates the stock is a holding.
